Volumetric MRI and cognitive measures in Alzheimer diseaseComparison of markers of progression

被引:0
|
作者
B. H. Ridha
V. M. Anderson
J. Barnes
R. G. Boyes
S. L. Price
M. N. Rossor
J. L. Whitwell
L. Jenkins
R. S. Black
M. Grundman
N. C. Fox
机构
[1] University College London,Dementia Research Centre, Institute of Neurology
[2] Wyeth Pharmaceuticals,Dept. of Radiology
[3] Elan Pharmaceuticals,undefined
[4] Inc.,undefined
[5] Mayo Clinic,undefined
来源
Journal of Neurology | 2008年 / 255卷
关键词
Alzheimer's disease; volumetric MRI measures; cognitive scales; clinical trials;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:567 / 574
页数:7
相关论文
共 50 条
  • [1] Volumetric MRI and cognitive measures in Alzheimer disease - Comparison of markers of progression
    Ridha, Basil H.
    Anderson, Valerie M.
    Barnes, Josephine
    Boyes, Richard G.
    Price, Shona L.
    Rossor, Martin N.
    Whitwell, Jennifer L.
    Jenkins, Lisa
    Black, Ronald S.
    Grundman, Michael
    Fox, Nick C.
    JOURNAL OF NEUROLOGY, 2008, 255 (04) : 567 - 574
  • [2] Combining Polygenic Hazard Score With Volumetric MRI and Cognitive Measures Improves Prediction of Progression From Mild Cognitive Impairment to Alzheimer's Disease
    Kauppi, Karolina
    Fan, Chun Chieh
    McEvoy, Linda K.
    Holland, Dominic
    Tan, Chin Hong
    Chen, Chi-Hua
    Andreassen, Ole A.
    Desikan, Rahul S.
    Dale, Anders M.
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [3] Combinatorial Markers of Mild Cognitive Impairment Conversion to Alzheimer's Disease - Cytokines and MRI Measures Together Predict Disease Progression
    Furney, Simon J.
    Kronenberg, Deborah
    Simmons, Andrew
    Guentert, Andreas
    Dobson, Richard J.
    Proitsi, Petroula
    Wahlund, Lars Olof
    Kloszewska, Iwona
    Mecocci, Patrizia
    Soininen, Hilkka
    Tsolaki, Magda
    Vellas, Bruno
    Spenger, Christian
    Lovestone, Simon
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 : 395 - 405
  • [4] Effect of Cognitive Reserve Markers on Alzheimer Pathologic Progression
    Lo, Raymond Y.
    Jagust, William J.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2013, 27 (04): : 343 - 350
  • [5] MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease
    El Fakhri, G
    Kijewski, MF
    Johnson, KA
    Syrkin, G
    Killiany, RJ
    Becker, JA
    Zimmerman, RE
    Albert, MS
    ARCHIVES OF NEUROLOGY, 2003, 60 (08) : 1066 - 1072
  • [6] Automated MRI measures predict progression to Alzheimer's disease
    Desikan, Rahul S.
    Cabral, Howard J.
    Settecase, Fabio
    Hess, Christopher P.
    Dillon, William P.
    Glastonbury, Christine M.
    Weiner, Michael W.
    Schmansky, Nicholas J.
    Salat, David H.
    Fischl, Bruce
    NEUROBIOLOGY OF AGING, 2010, 31 (08) : 1364 - 1374
  • [7] Conventional MRI volumetric measures of parietal and insular cortex in Alzheimer's disease
    Foundas, AL
    Eure, KF
    Seltzer, B
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1996, 20 (07): : 1131 - 1144
  • [8] MRI Measures of Hippocampus in Mild Cognitive Impairment and Alzheimer Patients
    Oncel, Cagatay
    Ozdemir, Bulent
    Erdogan, Cagdas
    Kiroglu, Yilmaz
    Sahiner, Turker
    TURKISH JOURNAL OF NEUROLOGY, 2011, 17 (04) : 181 - 184
  • [9] Validating MRI measures of disease stage and progression in Alzheimer's disease
    Jack, CR
    LIVING BRAIN AND ALZHEIMER'S DISEASE, 2004, : 75 - 86
  • [10] Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment
    Fleisher, A. S.
    Sun, S.
    Taylor, C.
    Ward, C. P.
    Gamst, A. C.
    Petersen, R. C.
    Jack, C. R., Jr.
    Aisen, P. S.
    Thal, L. J.
    NEUROLOGY, 2008, 70 (03) : 191 - 199